HeartWare Expects To Resolve MVAD Controller Issue By Early 2016
This article was originally published in Clinica
Executive Summary
HeartWare says it has fixed the software and manufacturing problems that led to the suspension of the MVAdvantage European trial of the MVAD miniaturized ventricular assist device in September. The company now believes the trial will be back on track in early 2016.